Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to Know

Pfizer (NYSE: PFE) announced on Tuesday that it had signed an agreement with the White House that will help Americans pay lower prices for prescription drugs and bolster U.S. leadership in biopharmaceutical innovation. The big pharmaceutical company will be involved in a website called "TrumpRx" that will help patients find discount prescription drugs and link them to manufacturers' direct-to-consumer websites. President Donald Trump and Pfizer CEO Albert Bourla spoke at a press conference to discuss the historic deal. The president said, "The American consumers have been subsidizing research and development for the entire planet. They put all of that on us, and yet they were the beneficiaries, too. So it's been changed." Bourla seemed to agree, stating, "I think today we are turning the tide, and we are reversing an unfair situation." What does this mean for anyone who owns or is interested in buying Pfizer stock? Here's what investors need to know.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool